Literature DB >> 1328951

Agranulocytosis in a haemodialysed patient induced by a proteinase inhibitor, nafamostate mesilate.

H Okada, H Suzuki, N Deguchi, T Saruta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1328951     DOI： 10.1093/ndt/7.9.980a

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  8 in total

Review 1.  Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

Authors:  H M Oudemans-van Straaten; J P J Wester; A C J M de Pont; M R C Schetz
Journal:  Intensive Care Med       Date:  2006-02-02       Impact factor: 17.440

2.  The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  J Intensive Care       Date:  2018-08-13

Review 3.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

4.  Section 5: Dialysis Interventions for Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

5.  Anaphylactic Reactions Caused by Nafamostat Mesylate during Hemodialysis before Surgery for Carpal Tunnel Syndrome.

Authors:  Yuta Nakamura; Kaoru Tada; Masashi Matsuta; Atsuro Murai; Hiroyuki Tsuchiya
Journal:  Case Rep Nephrol       Date:  2021-12-29

Review 6.  Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2).

Authors:  Norbert Lameire; John A Kellum
Journal:  Crit Care       Date:  2013-02-04       Impact factor: 9.097

7.  Ability of nafamostat mesilate to prolong filter patency during continuous renal replacement therapy in patients at high risk of bleeding: a randomized controlled study.

Authors:  Yong Kyu Lee; Hae Won Lee; Kyu Hun Choi; Beom Seok Kim
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

8.  Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial.

Authors:  Ji-Young Choi; Yun-Jeong Kang; Hye Min Jang; Hee-Yeon Jung; Jang-Hee Cho; Sun-Hee Park; Yong-Lim Kim; Chan-Duck Kim
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.